SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of ...
Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis is scheduled for mid-April 2026. SAN DIEGO, Feb. 03, ...
Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis is scheduled for mid-April 2026. SAN DIEGO, Feb. 03, ...
New York, New York--(Newsfile Corp. - February 4, 2026) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, is ...
TL;DR: Intel's new Xeon 600 "Granite Rapids" workstation CPUs deliver up to 86 cores and 172 threads, 128 PCIe Gen5 lanes, and support for 8000 MT/s DDR5 memory. Designed for professionals and AI ...
Skyryse, an El Segundo, California-based aviation automation startup, has raised more than $300 million in a Series C investment, pushing its valuation to $1.15 billion and into unicorn territory. The ...